Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by inventorson Apr 02, 2019 3:24pm
278 Views
Post# 29571942

Spinning

SpinningOuch...another disrespectful promise. What was said a year ago, repeated last fall, and still no deal, just a forward looking statement from two years ago? To save momentum, BLA resubmission was never done, nor any time soon on voucher, neither new money. Anyone bought, no doubt lost any return of their investment. Uncertain longs have been wiped out, sell home, default on cards, and fend off creditors, and after several years, promise of H2. That is why they have debt restructuring over the next 6 years. The H2 may as well be April 1 2020, less a day. End of H2 reporting? Nice partners that can't deliver, SRAM became Cantors-Friz vulture into submission. Now everyone else wants the same deal in reverse pecking order, and even exiting partners are creaming their jeans on 0.15-0.18. so the market might trash it down to 0.07 because they are reeling on capitulation of poor timelines. The excuse of not having a process up and running after telling us only 3 batches to complete a BLA, or some kind of voucher never happened either? this should have been accomplished by now. Not extended to actually wait for a potential larger partner order...ha. Here's to living off gift cards to no avail? I'll have to upchuck to rewrite something nice sooner than later, but don't hold your breath.
Bullboard Posts